Vimarsana
Biggest News Aggregation in the World

Page 2 - Control Arm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Control Arm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Control Arm Today - Breaking & Trending Today

Dassault Systèmes: Raising 2022 EPS Objectives on Good First Quarter Performance - Vimarsana News

Dassault Systèmes: Raising 2022 EPS Objectives on Good First Quarter Performance

27.04.2022 - Press Release VELIZY-VILLACOUBLAY, France — April 27, 2022 Dassault Systèmes: Raising 2022 EPS Objectives on Good First Quarter Performance Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA), today announced IFRS unaudited financial results ...

Dassault Systèmes SE (DASTY) CEO Bernard Charles on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Dassault Systèmes SE (DASTY) CEO Bernard Charles on Q1 2022 Results - Earnings Call Transcript

Dassault Systèmes SE. (OTCPK:DASTY) Q1 2022 Earnings Conference Call April 27, 2022, 09:00 AM ET Company Participants François-José Bordonado - VP, IR Bernard Charles - Vice Chairman &...

Novartis (NVS) Announces Data on Radioligand Therapy at ASCO - Vimarsana News

Novartis (NVS) Announces Data on Radioligand Therapy at ASCO

Novartis (NVS) posts results from a late-stage study on radioligand therapy at the 2021 ASCO.

Source: yahoo.com
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil - Vimarsana News

Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil

Share this article Share this article SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the clinical trial (the "Trial") of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board ("IRB") of Brazil. The trial was accepted for accelerated review. We have received support from the Brazilian government in terms of medical resources allocation and expect to start with the patients recruitment over the coming weekend. The Trial is a double-blinded, randomized and multi-center inves...

CNN Anthony Bourdain Parts Unknown May 14, 2015 01:25:00 - Vimarsana News

CNN Anthony Bourdain Parts Unknown May 14, 2015 01:25:00

Joining me jeffrey toobin and david sousie and a ntsb train member. and now we know it was going through the turn and there are questioning and what are the factors that you as an investigator would want to look at right now? >> well, you know, 11 or 12 minutes out of the station to be going that fast, i would want to know and the recorder should tell us that, just what the throttle settings were. did he go full throttle when he left the station? how did we get that fast in a short period of time. there are people that have started to look at the performance of the locomotive which we publishe...